Skip to content
GLP-1 Savers
Menu
Ranked #107 · Fair Price

Medro review

Medro (Medro Health Technologies, Inc.) is a telehealth brand whose GLP-1 program offers compounded semaglutide and tirzepatide, plus brand-name GLP-1s when eligible, via a partner medical group and…

Est. first month

From $199/mo (compounded)

Save ~85% vs brand-name
Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The published figure is a single-tier rate, not a price that is guaranteed at every dose. Confirm the current terms on the provider's own site before you commit.
Semaglutide
From $199/mo (compounded)
Tirzepatide
From $299/mo (compounded)
Coverage
All 50 states
Brand-name
Yes

The Value Score card

Medro scored on our six published factors. See the methodology.

Lowest Real Price72/100
No Teaser-Rate Bait60/100
Nationwide Availability96/100
Both Molecules92/100
Easy Cancellation95/100
Reputation64/100

Why it's a deal

  • Covers both compounded semaglutide and tirzepatide and can prescribe brand-name GLP-1s when clinically appropriate.
  • LegitScript-certified (seal #50716646), available in all 50 states, with tiered pricing shown before checkout.
  • No membership fee and free expedited shipping on all orders; online intake with no appointment required in many cases.
  • Prices drop with longer commitments (semaglutide to $149/mo, tirzepatide to $224/mo on a 12-month plan).

Read the fine print

  • Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.
  • Pricing is described as illustrative and may change by dose, pharmacy availability, and eligibility — final cost shows only at checkout.
  • Very new brand (2026, trademark pending) spanning many verticals, with a short track record in GLP-1 care.
  • Compounded medications are not FDA-approved or therapeutically equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound.

The bottom line

Best for: Shoppers who want compounded or brand semaglutide/tirzepatide with transparent tiered pricing and no membership, all 50 states. Medro (Medro Health Technologies, Inc.) is a telehealth brand whose GLP-1 program offers compounded semaglutide and tirzepatide, plus brand-name GLP-1s when eligible, via a partner medical group and…

Ranked #107 of 395 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Medro, out of 394 others we track.

Shopping Medro against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Medro, and every program that undercuts or outscores it is ranked on the Medro alternatives board.

More programs we track (24)

364 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Medro's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Medro's site. Not medical advice; see our disclosure.

← Back to all deals